Dr Daniel David Opheim, MD | |
1212 Pleasant St Ste 211, Des Moines, IA 50309-1411 | |
(515) 875-9770 | |
(515) 875-9771 |
Full Name | Dr Daniel David Opheim |
---|---|
Gender | Male |
Speciality | Colorectal Surgery (proctology) |
Experience | 18 Years |
Location | 1212 Pleasant St Ste 211, Des Moines, Iowa |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295821569 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Unitypoint Health - Des Moines Iowa Methodist Medi | Des moines, IA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
The Iowa Clinic Pc | 4082513742 | 273 |
News Archive
Nabi Biopharmaceuticals announced today that it has completed enrollment in the second Phase III clinical trial of NicVAX® (Nicotine Conjugate Vaccine), the company's innovative and proprietary investigational candidate vaccine being developed to treat nicotine addiction and prevent smoking relapse.
Aerobic exercise may reduce the risk of diabetes-related kidney disease in some people, according to a new study. The findings are published ahead of print in the American Journal of Physiology-Renal Physiology and was chosen as an APS select article for December.
Pro-smoking content, some featuring explicit cigarette brand images, is being promoted in smartphone apps reaching millions of users worldwide, including teenagers and children.
A study conducted by researchers in Germany has found that the B.1.617 variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has emerged in India entered certain types of lung and intestine cells with slightly increased efficiency compared with the original wild-type strain.
› Verified 9 days ago
Entity Name | The Iowa Clinic Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346233178 PECOS PAC ID: 4082513742 Enrollment ID: O20040102000222 |
News Archive
Nabi Biopharmaceuticals announced today that it has completed enrollment in the second Phase III clinical trial of NicVAX® (Nicotine Conjugate Vaccine), the company's innovative and proprietary investigational candidate vaccine being developed to treat nicotine addiction and prevent smoking relapse.
Aerobic exercise may reduce the risk of diabetes-related kidney disease in some people, according to a new study. The findings are published ahead of print in the American Journal of Physiology-Renal Physiology and was chosen as an APS select article for December.
Pro-smoking content, some featuring explicit cigarette brand images, is being promoted in smartphone apps reaching millions of users worldwide, including teenagers and children.
A study conducted by researchers in Germany has found that the B.1.617 variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has emerged in India entered certain types of lung and intestine cells with slightly increased efficiency compared with the original wild-type strain.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Daniel David Opheim, MD Po Box 424, Des Moines, IA 50302-0424 Ph: (515) 875-9255 | Dr Daniel David Opheim, MD 1212 Pleasant St Ste 211, Des Moines, IA 50309-1411 Ph: (515) 875-9770 |
News Archive
Nabi Biopharmaceuticals announced today that it has completed enrollment in the second Phase III clinical trial of NicVAX® (Nicotine Conjugate Vaccine), the company's innovative and proprietary investigational candidate vaccine being developed to treat nicotine addiction and prevent smoking relapse.
Aerobic exercise may reduce the risk of diabetes-related kidney disease in some people, according to a new study. The findings are published ahead of print in the American Journal of Physiology-Renal Physiology and was chosen as an APS select article for December.
Pro-smoking content, some featuring explicit cigarette brand images, is being promoted in smartphone apps reaching millions of users worldwide, including teenagers and children.
A study conducted by researchers in Germany has found that the B.1.617 variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has emerged in India entered certain types of lung and intestine cells with slightly increased efficiency compared with the original wild-type strain.
› Verified 9 days ago